Direkt zum Inhalt
Merck
  • Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.

Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.

Polish journal of pharmacology and pharmacy (1989-11-01)
A Fronczak, J Drzewoski, P Polakowski
ZUSAMMENFASSUNG

4'-epidoxorubicin (4'-epiDXR) was compared with doxorubicin (DXR) for myocardial effects in rabbits. Histologically, both drugs when given for six weeks induced a high incidence of diffused myocardial damage. The myocardial damage was less evident in rabbits treated with 4'-epiDXR than DXR for 3 weeks. Functionally 4'-epiDXR like DXR significantly reduced cardiac index (CI), stroke index (SI) and mean arterial blood pressure (MAP).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Deslanosid, European Pharmacopoeia (EP) Reference Standard
Preise und Verfügbarkeit sind derzeit nicht verfügbar.